TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15338257

Group type: COMPARATOR
Intervention: Anti-oxLDL levels in SLE patients with APS
Number of subjects: 70

Group type: COMPARATOR
Intervention: Anti-oxLDL levels in SLE patients without APS
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Reactive oxygen species production in SLE patients without APS
Number of subjects: 70

Group type: COMPARATOR
Intervention: oxLDL levels in APS patients
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Correlation of Anti-oxLDL levels with anticardiolipin antibodies
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Correlation of Anti-oxLDL levels with beta(2)-glycoprotein I antibodies
Number of subjects: 70
Study: 11349744

Group type: EXPERIMENTAL
Intervention: Continuous infusion of ceftazidime 3 g/day
Number of subjects: 35

Group type: COMPARATOR
Intervention: Intermittent infusion of ceftazidime 2 g 3 times/day
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Continuous infusion of ceftazidime
Number of subjects: 35

Group type: COMPARATOR
Intervention: Intermittent infusion of ceftazidime
Number of subjects: 35
Study: 9625813

Group type: EXPERIMENTAL
Intervention: Induction therapy with modified CODBLAM IV regimen
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Ara‐C at low doses plus alphaIFN
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: CCNU + vinblastine
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: alphaIFN as maintenance therapy
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Overall survival and failure-free survival rates
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Median follow-up
Number of subjects: 54
Study: 7943077

Group type: EXPERIMENTAL
Intervention: Prostaglandin E2 gel (0.5 mg, two doses 6 hours apart)
Number of subjects: 158

Group type: COMPARATOR
Intervention: Low-dose oxytocin (12 hours, up to 4 mlU/min)
Number of subjects: 158
Study: 3286393

Group type: EXPERIMENTAL
Intervention: Ritodrine infusion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Physiological saline (control)
Number of subjects: 0
Study: 31978882

Group type: EXPERIMENTAL
Intervention: 100 mg of preoperative hydrocortisone (group HC, n = 20)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Normal saline (group C, n = 20)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Postoperative 3-month pituitary hormone outcomes including ACTH deficiency
Number of subjects: 40
Study: 30446594

Group type: EXPERIMENTAL
Intervention: IV glyburide
Number of subjects: 77

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 77
Study: 26830074

Group type: EXPERIMENTAL
Intervention: Insulin therapy alone (32%) or in combination with other agents (17%)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oral agents
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Beta blockers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Statins
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 0
Study: 24755214

Group type: EXPERIMENTAL
Intervention: Tailored de-implementation strategy (interactive education, feedback in educational outreach visits, electronically sent reports on hospital performance, information letters/emails)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control strategy (passive dissemination of available evidence)
Number of subjects: 20
Study: 23307105

Group type: EXPERIMENTAL
Intervention: Topical fluoroquinolone use at presentation
Number of subjects: 480

Group type: EXPERIMENTAL
Intervention: Fourth-generation fluoroquinolones
Number of subjects: 480
Study: 20629549

Group type: EXPERIMENTAL
Intervention: Cryopreserved amniotic membrane (CAM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (conventionally managed lesions)
Number of subjects: 0
Study: 17551931

Group type: EXPERIMENTAL
Intervention: First-event-only method
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Marginal method
Number of subjects: 400
Study: 16175188

Group type: EXPERIMENTAL
Intervention: Baseline CA19-9 above median value
Number of subjects: 154

Group type: COMPARATOR
Intervention: Baseline CA19-9 below median value
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Fall of 20% in CA19-9 level from baseline
Number of subjects: 154
Study: 12514592

Group type: EXPERIMENTAL
Intervention: 4-mm to 7-mm grafts
Number of subjects: 109

Group type: COMPARATOR
Intervention: 6-mm grafts
Number of subjects: 109
Study: 10821722

Group type: EXPERIMENTAL
Intervention: Bambuterol (10 mg oral solution once daily)
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Bambuterol (10 mg or 20 mg tablets once daily)
Number of subjects: 141

Group type: COMPARATOR
Intervention: Terbutaline (0.075 mg/kg oral solution three times daily)
Number of subjects: 141

Group type: COMPARATOR
Intervention: Terbutaline (2.5 mg tablets three times daily)
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Both treatments (Bambuterol and Terbutaline)
Number of subjects: 141
Study: 8876850

Group type: EXPERIMENTAL
Intervention: Methyl salicylate (12.5%) applied as an ointment, 5 g twice daily for 4 days (8 doses)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Trolamine salicylate (10%) applied as a cream, 5 g twice daily for two doses
Number of subjects: 12
Study: 1545094

Group type: EXPERIMENTAL
Intervention: Skin prick tests (SPTs) to 10 fish species
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Oral challenges to fish species
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Immunoblot analyses with sera from fish-allergic patients
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: ELISA‐inhibition assays
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Consumption of other fish species
Number of subjects: 11
Study: 6694555

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Timolol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Propylthiouracil (PTU)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 30717811

Group type: EXPERIMENTAL
Intervention: SPECT/CT-aided SLNE
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard SLNE
Number of subjects: 0
Study: 30304428

Group type: EXPERIMENTAL
Intervention: Polymyxin B hemoperfusion plus standard therapy (n=224 patients)
Number of subjects: 450

Group type: COMPARATOR
Intervention: Sham hemoperfusion plus standard therapy (n=226 patients)
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Polymyxin B hemoperfusion plus standard therapy (n=146 patients with MODS > 9)
Number of subjects: 450

Group type: COMPARATOR
Intervention: Sham hemoperfusion plus standard therapy (n=148 patients with MODS > 9)
Number of subjects: 450
Study: 27900995

Group type: EXPERIMENTAL
Intervention: WeChat follow-up (WFU)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Telephone follow-up (TFU)
Number of subjects: 108
Study: 24518646

Group type: EXPERIMENTAL
Intervention: Community Health Workers/Promotores de Salud (CHW/PS) services
Number of subjects: 444

Group type: COMPARATOR
Intervention: Community resources utilization
Number of subjects: 444
Study: 23029625

Group type: EXPERIMENTAL
Intervention: Cognitive training (4-month paper-pencil and PC-based guided intervention)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cognitive training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Social control
Number of subjects: 0

Group type: COMPARATOR
Intervention: No-contact control
Number of subjects: 0
Study: 21037440

Group type: EXPERIMENTAL
Intervention: Early Surgery (ES)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Preoperative Biliary Drainage (PBD)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Time to surgery
Number of subjects: 180
Study: 17413108

Group type: EXPERIMENTAL
Intervention: Exclusive breastfeeding counseling
Number of subjects: 98

Group type: COMPARATOR
Intervention: Standard health care messages (Control)
Number of subjects: 98
Study: 16215330

Group type: EXPERIMENTAL
Intervention: Manual therapy with specific adjuvant exercise
Number of subjects: 100

Group type: COMPARATOR
Intervention: Sham manual therapy with specific adjuvant exercise
Number of subjects: 100
Study: 11991778

Group type: EXPERIMENTAL
Intervention: Daily Undulating Periodization (DUP)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Linear Periodization (LP)
Number of subjects: 20
Study: 10754344

Group type: EXPERIMENTAL
Intervention: Elevated plasma apolipoprotein B levels
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Intracellular magnesium levels
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Fasting blood glucose
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Total cholesterol
Number of subjects: 42
Study: 7530501

Group type: EXPERIMENTAL
Intervention: R760Q mutation
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Other arginine substitutions (R760W, R760Q, R808C, R870W)
Number of subjects: 17
Study: 2191977

Group type: EXPERIMENTAL
Intervention: Topical application of autologous fibronectin with citric acid demineralisation
Number of subjects: 4

Group type: COMPARATOR
Intervention: Citric acid demineralisation alone (Control)
Number of subjects: 4
Study: 356250

Group type: EXPERIMENTAL
Intervention: diclofenac sodium (Voltaren)
Number of subjects: 36

Group type: COMPARATOR
Intervention: indomethacin
Number of subjects: 36
Study: 30784233

Group type: EXPERIMENTAL
Intervention: Integrated preventive psychological intervention (IPPI) and N-acetyl-l-cysteine (NAC)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Integrated preventive psychological intervention (IPPI) and Placebo
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: N-acetyl-l-cysteine (NAC) and psychological stress management
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo and psychological stress management
Number of subjects: 200
Study: 28259151

Group type: EXPERIMENTAL
Intervention: internet-based cognitive behavioral therapy (iCBT)
Number of subjects: 974

Group type: EXPERIMENTAL
Intervention: simplified emotion-focused mindfulness (sEFM)
Number of subjects: 974

Group type: COMPARATOR
Intervention: waiting list control group
Number of subjects: 974
Study: 26218683

Group type: EXPERIMENTAL
Intervention: Number of fractured ribs
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: Each additional fractured rib
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: Lower rib fractures
Number of subjects: 189
Study: 23305133

Group type: EXPERIMENTAL
Intervention: Full-mouth disinfection (FMD) group: full-mouth scaling and root planing (FMSRP) within 24 hours + local application of chlorhexidine (CHX) gel + CHX rinses for 60 days
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control group: full-mouth scaling and root planing (FMSRP) within 24 hours + local application of placebo gel + placebo rinses for 60 days
Number of subjects: 38
Study: 21963017

Group type: EXPERIMENTAL
Intervention: Low-fat milk with micronutrients (LFM+M)
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Low-fat milk (LFM)
Number of subjects: 139

Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 139
Study: 19702819

Group type: EXPERIMENTAL
Intervention: AmF-SnF2 mouth rinse and toothpaste, used twice daily for 8 months
Number of subjects: 194

Group type: COMPARATOR
Intervention: Placebo mouth rinse and toothpaste, used twice daily for 8 months
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: AmF-SnF2 mouth rinse and toothpaste
Number of subjects: 194

Group type: COMPARATOR
Intervention: Placebo mouth rinse and toothpaste
Number of subjects: 194
Study: 16722802

Group type: EXPERIMENTAL
Intervention: Ketorolac 0.4% adjunctive regimen with cyclosporin-A
Number of subjects: 52

Group type: COMPARATOR
Intervention: Cyclosporin-A monotherapy
Number of subjects: 52
Study: 15031393

Group type: EXPERIMENTAL
Intervention: Workplace intervention aimed at increasing control and support at work
Number of subjects: 221

Group type: COMPARATOR
Intervention: Catering staff (control group)
Number of subjects: 221
Study: 11189544

Group type: EXPERIMENTAL
Intervention: Change Indicator Dressing (SIG)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Hydrocolloid Alginate Dressing (HAD)
Number of subjects: 35
Study: 9325829

Group type: EXPERIMENTAL
Intervention: Trial bandaging system
Number of subjects: 29

Group type: COMPARATOR
Intervention: Charing Cross bandaging system
Number of subjects: 29
Study: 8384186

Group type: EXPERIMENTAL
Intervention: ephedrine/caffeine combination (20mg/200mg)
Number of subjects: 180

Group type: COMPARATOR
Intervention: ephedrine (20mg)
Number of subjects: 180

Group type: COMPARATOR
Intervention: caffeine (200mg)
Number of subjects: 180

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 180
Study: 3770280

Group type: EXPERIMENTAL
Intervention: Oxytocin infusion managed according to routine delivery unit practice (n = 36)
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Oxytocin infusion rates halved (n = 45)
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Oxytocin infusion rates quartered (n = 43)
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Oxytocin infusion discontinued (n = 40)
Number of subjects: 164

Group type: COMPARATOR
Intervention: Fluid restriction during labour
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Hyponatraemic infants
Number of subjects: 164
Study: 30194644

Group type: EXPERIMENTAL
Intervention: Alone
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Dyad
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control
Number of subjects: 100
Study: 29145993

Group type: EXPERIMENTAL
Intervention: Synthetic bioabsorbable polymer spray
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 40
Study: 26801483

Group type: EXPERIMENTAL
Intervention: Immunoadsorption (IA) therapy using tryptophan column
Number of subjects: 40
Study: 24708773

Group type: EXPERIMENTAL
Intervention: Active video games with education and consultations for the family
Number of subjects: 40

Group type: COMPARATOR
Intervention: General recommendation for physical activity for 30 minutes per day (Control)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Active video games
Number of subjects: 40
Study: 22513514

Group type: EXPERIMENTAL
Intervention: 3T optimized protocol (triple dose of Gd, 20 min scan delay)
Number of subjects: 14

Group type: COMPARATOR
Intervention: 1.5T standard protocol (single dose of Gd, 5 min scan delay)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Healthy controls (HC)
Number of subjects: 14
Study: 20419359

Group type: EXPERIMENTAL
Intervention: Telephone counseling
Number of subjects: 434

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 434
Study: 18590111

Group type: EXPERIMENTAL
Intervention: anti-IF-gamma
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: anti-TNF-alpha
Number of subjects: 55

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 55
Study: 16096304

Group type: EXPERIMENTAL
Intervention: Motivational interviewing at home by specially trained midwives
Number of subjects: 762

Group type: COMPARATOR
Intervention: Standard health promotion information (Control)
Number of subjects: 762
Study: 12051282

Group type: EXPERIMENTAL
Intervention: Topical 0.1% diclofenac (Group A)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Topical 0.1% dexamethasone (Group B)
Number of subjects: 58
Study: 9925130

Group type: EXPERIMENTAL
Intervention: 250 microgram folic acid/d for 4 weeks
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: 500 microgram folic acid/d for 4 weeks
Number of subjects: 144

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 144
Study: 7773216

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin
Number of subjects: 20

Group type: COMPARATOR
Intervention: Co-trimoxazole
Number of subjects: 20
Study: 2245544

Group type: EXPERIMENTAL
Intervention: Core decompression
Number of subjects: 55

Group type: COMPARATOR
Intervention: Conservative management
Number of subjects: 55
Study: 7433477

Group type: EXPERIMENTAL
Intervention: Intramuscular injection of methylglucamine indomethacinate (average dose 72.6 mg)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Intravenous injection of methylglucamine indomethacinate (average dose 36.1 mg)
Number of subjects: 106
Study: 30176093

Group type: EXPERIMENTAL
Intervention: NCES prepared by 4C method
Number of subjects: 30

Group type: COMPARATOR
Intervention: lab‐NCES
Number of subjects: 30
Study: 26646593

Group type: EXPERIMENTAL
Intervention: Smartphone application + health coach intervention and counseling sessions
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control condition with a counseling session
Number of subjects: 62
Study: 26672982

Group type: EXPERIMENTAL
Intervention: Graphic images plus text
Number of subjects: 293

Group type: EXPERIMENTAL
Intervention: Graphic images with elaborated text
Number of subjects: 293

Group type: COMPARATOR
Intervention: Text only
Number of subjects: 293

Group type: EXPERIMENTAL
Intervention: Graphic images
Number of subjects: 293
Study: 23337440

Group type: EXPERIMENTAL
Intervention: Laplace (double-exponential) distribution
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Image contrast
Number of subjects: 0
Study: 22321682

Group type: EXPERIMENTAL
Intervention: Acellular tissue matrix patch during Lichtenstein herniorrhaphy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Traditional high ligation of hernial sac
Number of subjects: 60
Study: 19556260

Group type: EXPERIMENTAL
Intervention: Dual antiplatelet therapy
Number of subjects: 14703

Group type: EXPERIMENTAL
Intervention: Gastrointestinal bleeding
Number of subjects: 14703

Group type: EXPERIMENTAL
Intervention: Kaplan-Meier estimated rate of GI bleeding at 6 months
Number of subjects: 14703
Study: 17493498

Group type: EXPERIMENTAL
Intervention: Avoiding allergenic triggers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Timely administration of epinephrine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Experimental medications
Number of subjects: 0
Study: 15361183

Group type: EXPERIMENTAL
Intervention: Adjuvant platinum chemotherapy
Number of subjects: 463

Group type: COMPARATOR
Intervention: Total abdominal radiotherapy (in one randomized group)
Number of subjects: 463
Study: 11133793

Group type: EXPERIMENTAL
Intervention: Patients with anterior parietal lobe lesions
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Patients with posterior parietal lesions
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Patients with frontal lobe lesions
Number of subjects: 22

Group type: COMPARATOR
Intervention: Healthy volunteers
Number of subjects: 22
Study: 9335674

Group type: EXPERIMENTAL
Intervention: Psychosocial interventions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Randomised controlled trials (RCTs)
Number of subjects: 0
Study: 8170118

Group type: EXPERIMENTAL
Intervention: 3 word presentations
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 10 word presentations
Number of subjects: 30

Group type: COMPARATOR
Intervention: 0 word presentations (control condition)
Number of subjects: 30
Study: 3064920

Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 29108671

Group type: EXPERIMENTAL
Intervention: Metacognitive Reflection and Insight Therapy (MERIT‐EP)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 20
Study: 26700065

Group type: EXPERIMENTAL
Intervention: Vitamin A (25,000 IU/day for 3 months)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 24853306

Group type: EXPERIMENTAL
Intervention: Self-reported adherence (interview)
Number of subjects: 510

Group type: EXPERIMENTAL
Intervention: Self-reported adherence (computer-assisted self-interview)
Number of subjects: 510

Group type: EXPERIMENTAL
Intervention: Adherence estimated by pill count
Number of subjects: 510

Group type: EXPERIMENTAL
Intervention: Medication possession ratio
Number of subjects: 510

Group type: EXPERIMENTAL
Intervention: Drug detection (tenofovir diphosphate or emtricitabine triphosphate)
Number of subjects: 510
Study: 22476832

Group type: EXPERIMENTAL
Intervention: Virtual Reality Simulator (LapVR™)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Video Trainer (VT)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Crossover assessment (LapVR™ to VT and vice versa)
Number of subjects: 44
Study: 20575685

Group type: EXPERIMENTAL
Intervention: MPCNL
Number of subjects: 50

Group type: COMPARATOR
Intervention: PCNL
Number of subjects: 50
Study: 18842793

Group type: EXPERIMENTAL
Intervention: High-DHA group (1% DHA)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Control group (approximately 0.3% DHA)
Number of subjects: 115
Study: 16389917

Group type: EXPERIMENTAL
Intervention: Nonparametric adjustment techniques for binary covariates
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of two approaches for adjustment
Number of subjects: 0
Study: 12055815

Group type: EXPERIMENTAL
Intervention: Chloroquine
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Sulfadoxine-pyrimethamine (SP)
Number of subjects: 117
Study: 10353379

Group type: EXPERIMENTAL
Intervention: Patients with right frontal lesions
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Patients with right posterior lesions
Number of subjects: 80

Group type: COMPARATOR
Intervention: Non-brain-damaged patients (controls)
Number of subjects: 80
Study: 8556568

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate aqueous nasal spray (FPANS) 200 micrograms twice daily for 2 weeks
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate aqueous nasal spray (FPANS)
Number of subjects: 24
Study: 1971216

Group type: EXPERIMENTAL
Intervention: 443C81 (synthetic enkephalin)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Dipipanone (10 mg, oral)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 443C81
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Dipipanone
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: All active treatments (443C81 and dipipanone)
Number of subjects: 12
Study: 7004809

Group type: EXPERIMENTAL
Intervention: Portacaval anastomosis (PCA)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Unoperated control subjects
Number of subjects: 90
Study: 29124951

Group type: EXPERIMENTAL
Intervention: Motivational health promotion intervention adapted for persons with SMI
Number of subjects: 20
Study: 28922226

Group type: EXPERIMENTAL
Intervention: Inhalation of 80% oxygen
Number of subjects: 25

Group type: COMPARATOR
Intervention: Inhalation of 30% oxygen
Number of subjects: 25
Study: 25587804

Group type: EXPERIMENTAL
Intervention: ECC training tailored by a low RPE (RPE between 9 and 11)
Number of subjects: 42

Group type: COMPARATOR
Intervention: CON training tailored by heart rate at the first ventilatory threshold
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: ECC training
Number of subjects: 42

Group type: COMPARATOR
Intervention: CON training
Number of subjects: 42